Cargando…
Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer
Breast cancer is the most prevalent malignancy among women worldwide and hereditary breast cancer (HBC) accounts for about 5–10% of the cases. Today, the most recurrent genes known are BRCA1 and BRCA2, accounting for around 25% of familial cases. Although thousands of loss-of-function variants in mo...
Autores principales: | Liu, Yaxuan, Helgadottir, Hafdis T., Kharaziha, Pedram, Choi, Jungmin, López-Giráldez, Francesc, Mane, Shrikant M., Höiom, Veronica, Juhlin, Carl Christofer, Larsson, Catharina, Bajalica-Lagercrantz, Svetlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138793/ https://www.ncbi.nlm.nih.gov/pubmed/35625741 http://dx.doi.org/10.3390/biomedicines10051004 |
Ejemplares similares
-
Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2021) -
Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020) -
Sequencing for germline mutations in Swedish breast cancer families reveals novel breast cancer risk genes
por: Helgadottir, Hafdis T., et al.
Publicado: (2021) -
Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells
por: Pellegrini, Paola, et al.
Publicado: (2016) -
BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile
por: Alvarez, Carolina, et al.
Publicado: (2017)